Female | Male | Total | |
---|---|---|---|
N | 249 | 384 | 633 |
Age (years) | 52.7 (18.4) | 52.5 (18.9) | 52.6 (18.7) |
BMI (kg/m2) | 26.5 (5.8) | 28.1 (10.3) | 27.4 (8.9) |
General health (1, bad; 4, excellent) | 2.7 (0.9) | 2.7 (0.8) | 2.7 (0.8) |
Ever-smoking | 104 (42%) | 190 (49%) | 294 (46%) |
Hypertension | 191 (77%) | 334 (88%) | 525 (83%) |
Duration of HT (years) | 7.2 (8.7) | 8.0 (8.4) | 7.7 (8.5) |
Number of anti-hypertensive drugs | 1.2 (1.2) | 1.6 (1.4) | 1.5 (1.3) |
Systolic BP (mmHg) | 129.9 (18.3) | 135.3 (15.3) | 133.2 (16.8) |
Diastolic BP (mmHg) | 76.8 (9.2) | 79.6 (9.4) | 78.5 (9.4) |
ACEi/ARB (%) | 107 (41%) | 205 (52%) | 312 (48%) |
Diabetes (%) | 26 (10%) | 74 (19%) | 100 (16%) |
Diabetes duration (years) | 13.7 (10.8) | 15.6 (11.2) | 15.1 (11.1) |
DM-complications (%) | 9 (35%) | 41 (55%) | 50 (50%) |
CVD (%) | 35 (14%) | 108 (28%) | 143 (23%) |
Autoimmune diseases (%) | 58 (22%) | 79 (20%) | 137 (21%) |
Chronic infections (%) | 5 (2%) | 11 (3%) | 16 (2%) |
Chronic liver disease (%) | 11 (4%) | 5 (2%) | 16 (2%) |
Chronic obstructive lung disease (%) | 22 (8%) | 23 (6%) | 45 (7%) |
History of cancer (%) | 33 (13%) | 39 (10%) | 72 (11%) |